Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2009

May 26, 2009

34975_dirs_2009-05-26_aa6e21c9-5195-4705-9b75-50466d1dd6bf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2009-05-21

Reporting Person: LUSCINSKI SUSAN M (Chief Operating Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-05-21 Stock Option (right to buy) $3.18 A 200000 Acquired 2019-05-21 Common Stock, par value $0.01 per share (200000) Direct

Footnotes

F1: The shares vest in four equal installments on the first four anniversaries of January 1, 2009.